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2160ABSTRACT
Background. The cold ischemia time (CIT) is a period of time between harvesting an
organ for transplant and its reperfusion just after implantation. CIT may have an impact on
frequency of complications after lung transplant that can be treated by means of bron-
choscopic intervention. The aim of the study was to investigate the correlation between
CIT and frequency of bronchoscopic intervention.
Methods. The retrospective study consists of 91 patients: 22 single lung recipients (24%)
and 69 double lung recipients (76%) who underwent lung transplant from March 2012 to
June 2019. All statistical analyses were performed in SPSS 25.0 and R 3.5.3. The P levels
less than .05 were deemed statistically significant.
Results. The average CIT in single lung transplant was 5.91 hours, and in double lung
transplant it was 8.61 hours. For the 4- to 8-hour CIT the percentages were 80.95% for
single lung recipients and 46.38% for double lung recipients. For CIT longer than 8
hours, the following percentages were observed: 9.53% in single lung transplant and
53.62% in double lung transplant. Each subsequent hour of CIT exponentially increases
the risk of intervention 1505 times (50.05%).
Conclusions. Prolonged CIT seems to be a risk factor for airway complication, especially
in the double lung recipient group.*Address correspondence to Anastazja Pandel, Silesian Centre
for Heart Diseases, ul. Marii Skłodowskiej-Curie 9 Pawilon C, 41-
800 Zabrze, Poland. E-mail: anasazja@hotmail.comLUNG transplant (LTx) remains the only therapeuticoption for patients with end-stage lung diseases [1].
Despite enormous progress in the selection of donors and
recipients and improvement both in surgical techniques and
postoperative patient management, LTx is still associated
with a relatively high risk of complications (2%-32%) [2e6].
Some of the most significant problems are airway compli-
cations (ACs), which include airway stenosis, dehiscence of
the bronchial anastomoses, and various forms of impaired
healing (excess of necrotic tissue or hypertrophic granula-
tion). The main factors that are considered to have an
impact on occurrence of ACs include cold ischemia time
(CIT), length of the donor bronchi, surgical technique, use
of mechanical ventilation, immunosuppressive agents,
postoperative infections, and more [7e9]. Nevertheless,
because of the lack of a widespread scale for respiratory0
rg/10.1016/j.transproceed.2020.03.047complications after LTx, the assessment of their frequency
performed by different LTx facilities produces various re-
sults, making the research set on evaluating its impact very
difficult.
Therefore, there are still doubts because of the lack of
conclusive data whether the length o CIT has a significant
impact on the frequency of complications after transplant
[10e15].
According to the Registry of the International Society for
Heart and Lung Transplantation the median CIT in doubleª 2020 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1. Demographic Features of the Studied Group
Variables SLT (n ¼ 22) DLT (n ¼ 69) P Value
Recipient Related
Age, mean (SD), y 46.91 (12.81) 35.97 (14.27) .002
Female sex, No. (%) 8 (36.36) 29 (42.03) .638
COLD ISCHEMIA TIME AND AIRWAY COMPLICATION 2161lung transplant (DLT) was 5.5 hours, while single lung
transplant (SLT) had a median CIT of 4.2 hours [10].
The aim of the study was to investigate the whether there
is a correlation between CIT and the frequency of bron-
choscopic intervention (BI).Diagnosis, No. (%)
CF 0 (0) 31 (44.93) .004
COPD 10 (45.45) 16 (23.19)
ILD 8 (36.36) 14 (20.29)
IPAH 3 (13.64) 6 (8.7)
Other 1 (4.55) 2 (2.9)
BMI, mean (SD) 21.73 (3.64) 20.45 (3.79) .169
GFR, mean (SD), mL/min/
1.73m2
97.49 (36.34) 133.18 (55.76) .006
HGB, mean (SD), mmol/L 11.71 (2.67) 11.67 (3.11) .963
RBC, mean (SD), millions/
mL
5.21 (0.88) 5.03 (0.74) .350
HCT, mean (SD) 44.3 (4.24) 42.68 (5.89) .254
FEV1, mean (SD), % 44.47 (27.41) 26.82 (15.44) .030
FVC,% 60.1 (20.96) 43.1 (16.5) .003
Donor Related
Age, mean (SD), y 38.73 (13.35) 37.45 (12.5) .682
Female sex, No. (%) 7 (31.82) 25 (38.46) .576
BMI, mean (SD) 23.25 (2.56) 23.53 (2.8) .671
Cause of Death, No. (%)
Brain hemorrhage 11 (50) 36 (55.38) .679
Head trauma 10 (45.45) 24 (36.92)
Stroke 0 (0) 3 (4.62)
Other 1 (4.55) 2 (3.08)
Transplant Related, mean
(SD)
Waiting time, d 268.55 (347.77) 273.29 (282.97) .949
CIT, h 5.91 (1.93) 8.61 (2.12) < .001
1-y Follow-up
GFR, mL/min/1.73m2 46.65 (11.3) 58.82 (27.78) .015
RBC, millions/mL 3.99 (0.52) 3.88 (0.52) .476
HGB, mmol/L 7.34 (0.89 7.11 (0.89) .395
HCT 0.35 (0.04) 0.35 (0.04) .555
FEV1, % 58.08 (16.44) 66.92 (25.09) .234
FVC, % 72.08 (16.48) 76.02 (20.34) .521
5-y Follow-up
GFR, mL/min/1.73m2 52.1 (13.26) 57.6 (32.32) .703
RBC, millions/mL 4.38 (0.84) 4.69 (0.97) .550
HGB, mmol/L 7.5 (1.16) 8.04 (1.27) .432
HCT 0.37 (0.04) 0.39 (0.06) .351
FEV1, % 45.33 (16.17) 73.71 (32.55) .079
FVC, % 65 (15.3) 82 (10.34) .036
Abbreviations: BMI, body mass index (calculated as weight in kilograms
divided by height in meters squared); CF, cystic fibrosis; CIT, cold ischemia
time; COPD, chronic obstructive pulmonary disease; DLT, double lung trans-
plant; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity;
GFR, glomerular filtration rate; HCT, hematocrit; HGB, hemoglobin; ILD, inter-
stitial lung disease; IPAH, idiopathic pulmonary artery hypertension; RBC, red
blood cell; SLT, single lung transplant.MATERIALS AND METHODS
Patients
The study design was single-center retrospective cohort research.
We analyzed data from 91 patients with available data who un-
derwent LTx from April 2013 to June 2019 in Silesian Center for
Heart Diseases (Zabrze, Poland). Median age at referral for LTx
was 41 years old (range, 15-65 years). Heart-lung transplant and
retransplant recipients were excluded from the study. The number
of DLTs was 69 (75.82%). Demographic and clinical features of the
studied group with the division into SLT and DLT groups are
presented in Table 1.
Airway Complications
This article describes interventions required in case of any airway
stenosis (at the bronchial anastomosis or lower, eg, bronchus
intermedius), granulation, or the presence of necrotic tissue. No
patients presented with any type of anastomotic dehiscence;
therefore, such complication is not taken under consideration in
this study.
Surgical Technique
Bronchial anastomoses were performed after excision of native lung
and preparing the donor lung with absorbable sutures. Membranous
part was sewn with continuous suture of pds 4-0, and pds 3-0 single
sutures were used 1 per cartilage.
Organ Preservation
All of the lungs were flushed with extracellular, low-potassium,
dextran-based electrolyte preservation solution in accordance to
procurement protocol.
Cold Ischemia Time
CIT was defined as the time between aortic cross-clamp performed
during organ procurement surgery and lung allograft reperfusion
during LTx surgery. For DLTs the reperfusion of the second lung
defined the duration of CIT.
Statistical Analysis
All statistical analyses were performed in SPSS 25.0 (IBM, Armonk,
NY, United States) and R 3.5.3. The P levels less than .05 were
deemed statistically significant. For analyses involving number of
BIs, tests adequate for Poisson distribution were used since our data
consisted of counts in a given period of time. Specifically, uni- and
multivariate Poisson regression were used as well as Poisson test.
Interaction effect of variables in multivariate Poisson regression was
assessed with partial response plot. For dichotomous discrete var-
iables (occurrence or lack of intervention) multivariate logistic
regression analysis was performed.
For the analysis of demographic and clinical features of the
studied group Student t test was used.RESULTS
Described results are the effect of the analysis pertaining to
22 single lung recipients and 69 double lung recipients. The
average CIT in SLT was 5.91 hours, and in DLT it was 8.61
hours. A total of 9.52% of single lung recipients and 0% of
bilateral lung recipients had CIT less than 4 hours. For the
Table 3. Multivariate Poisson Regression Analysis: Impact on




Assessment SE c2 P Value OR
95% CI
Lower Upper
Age, y 0.022 0.035 0.404 .525 1.023 0.955 1.095
Sex, female 0.184 0.647 0.081 .776 1.202 0.338 4.276
BMI 0.275 0.132 4.332 .037 0.760 0.587 0.984
Diagnosis
CF 0.471 1.024 0.738 .691
COPD 0.903 1.056 0.212 .645 1.602 0.215 11.930
Other 1.340 0.957 0.732 .392 2.467 0.312 19.530
Diabetes 0.001 0.001 1.962 .161 0.262 0.040 1.707
Time on waiting
list > 365 d
0.409 0.193 0.793 .373 1.001 0.999 1.003
CIT 4.496 .034 1.505 1.031 2.195
Abbreviations: BMI, body mass index; CF, cystic fibrosis; CIT, cold ischemia
time; COPD, chronic obstructive pulmonary disease; OR, odds ratio.
2162 NĘCKI, ANTONCZYK, PANDEL ET AL4- to 8-hour CIT, the percentages were 80.95% for single
lung recipients and 46.38 for double lung recipients. When it
comes to CIT longer than 8 hours, we can observe the
following percentages: 9.53% in SLT and 53.62% in DLT.
In multivariate logistic regression analysis with CIT
included, the statistical significance in Table 2 relates to
Wald’s statistics determining the need for performing an
intervention. Statistically significant results encompassed
CIT and body mass index. Each subsequent hour of CIT
exponentially increases the risk of intervention 1505 times
(50.05%). The aforementioned analysis assessed that lesser
body mass index might increase need for BI. Nagelkerke’s
R2 model was used to confirm that multivariate logistic
regression analysis satisfactorily predicts the probability of
having to perform interventions (P ¼ .246).
With univariate logistic regression analysis the result of
CIT is not statistically significant (P ¼ .283; hazard ratio,
1.004; CI, 0.997-1.011).
The results of multivariate Poisson regression analysis are
presented in Table 3. If the procedure was performed
before 2018, the probability of performing an intervention
increases 3.6 times. Each subsequent hour of CIT expo-
nentially increases the risk of intervention by 15.7%. The
increase in donor age by every year escalates the chance of
intervention by 0.9%.
Figure 1 presents the impact of CIT and donor age on the
number of interventions required for a patient. If the donor
is young, we can observe a large association between the
duration of CIT and the number of interventions. With
donor age the impact of CIT duration decreases. At donor
age of 52 years we can hardly observe the impact of CIT on
the number of interventions.DISCUSSION
Our study assessed that the number of interventions in-
creases along with the duration of CIT. This observation
was especially noted among recipients who received lungs
from younger donors. Our study provided the results sug-
gesting that lungs procured from older donors are more
immune to ischemia. A similar issue was studied by Men-
dogni et al [13]. Their research determined that there is a
significant association between ACs and CIT, as prolonged
CIT seems to be a risk factor for late AC development.
Similar surgical technique involving absorbable mono-
filament sutures is used in our center as well. Their study
assessed the issue by univariate analysis, while the strengthTable 2. Multivariate Logistic Regression Analysis: Possibility of
Need for Bronchoscopic Intervention
Parameter
Parameter





1.281 0.1763 52.767 < .001 3.600 2.548 5.085
CIT, h 0.146 0.0387 14.276 < .001 1.157 1.073 1.249
Donor age, y 0.009 0.0045 3.879 .049 0.991 0.982 1.000
Abbreviations: CIT, cold ischemia time; OR, odds ratio.of our work is that it has proved that CIT is a valid risk
factor of AC in a multivariate regression analysis. Less
recent research published by Murthy et al does not prove
the connection between CIT and AC [5]. Donor age is also
believed to be a risk factor of death after LTx. However, our
research determined that older lungs are more immune to
the effects of ischemia because the number of the BIs rose
significantly with increase of CIT among patients with lungs
from younger donors, whereas the same effect was not
observed among recipients with lungs procured from older
donors. The article published by Mulvihill et al suggested
that even though prolonged CIT does not influence the
survival, donors older than 50 years can be a risk factor
associated with worse survival after LTx [16]. However,
there are studies that suggest that donor age and CIT do not
influence the survival as independent factors. The study by
Meyer et al also claims that those 2 combined demonstrated
a significantly worse survival at 2 years. Such combination
was also noted as significant by other articles [17]. Novick
et al state that not only older donors may have unfavorable
effect on survival. Their study also claims that very young
donors also may have a negative impact. An interesting
finding was reported among pediatric LTx recipients [18].
As it was published by Hayes et al, 4 to 6 hours of CIT was
associated with favorable outcome, whereas CIT of more
than 6 hours and less than 4 hours provided worse results
[19]. A provided explanation was that patient characteristics
(severity of condition) predispose transplant teams to select
geographically closer donors to avoid longer CIT as risk
factors of worse survival.
This issue requires further research because most trans-
plant centers’ goal is to have the shortest CIT possible.CONCLUSIONS
CIT influences the number of ACs that require BI. The
effect of CIT on the frequency of BI is particularly clear
among recipients with lungs from young donors. In the
Fig 1. Edge effects graph describing the correlation between the number of interventions [f(CIT)] and the duration of CIT with different
donor ages (20/38/52). CIT, cold ischemia time.
COLD ISCHEMIA TIME AND AIRWAY COMPLICATION 2163group of patients whose lungs were procured from older
donors, the number of interventions was not as influenced
by CIT. The study requires further investigations because
authors are aware of its limitations.
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